Is a complete PGEN research report available?

No complete published report is available for Precigen, Inc. (PGEN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Precigen, Inc. (PGEN)

NASDAQ: PGEN · USD

$6.09

-0.07 (-1.1%)· Recorded snapshot

Market cap	2.2B
Revenue (ttm)	85.7M
Net income (ttm)	-336.7M
EPS (ttm)	-$0.98
Shares out	358M
P/E (forward)	10.9x
Volume	3,092,184
Beta	0.92

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 85.7M
Net income (ttm): -336.7M
EPS (ttm): -$0.98
P/E (forward): 10.9x
Market cap: 2.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0001356090
Company name	Precigen, Inc.
Country	United States
Country code	US
CUSIP number	74017N105
Earnings date	2026-11-12
Earnings time	amc
Employees	160
Employees change	17
Employees growth	11.89%
Enterprise value	$2.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1998
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US74017N1054
Last 10-K release date	2026-03-25
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.2B
Market cap category	Mid-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$6.09
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	PGEN
U.S. state	Maryland
Website	https://precigen.com

Metric

Value

Amount currency

USD

CIK code

0001356090

Company name

Precigen, Inc.

Country

United States

Country code

CUSIP number

74017N105

Earnings date

2026-11-12

Earnings time

amc

Employees

160

Employees change

Employees growth

11.89%

Enterprise value

$2.2B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1998

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US74017N1054

Last 10-K release date

2026-03-25

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$2.2B

Market cap category

Mid-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$6.09

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

PGEN

U.S. state

Maryland

Website

https://precigen.com

Metric	Value
Earnings yield	-16.16%
EV/Sales	26.6x
FCF / EV yield	-5.05%
FCF yield	-5.19%
Forward EV/Sales	7.13x
Forward P/E	10.89x
Forward P/S	6.94x
P/B ratio	50.53x
P/S ratio	25.9x
Price / tangible book value	86.04x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-16.16%

EV/Sales

26.6x

FCF / EV yield

-5.05%

FCF yield

-5.19%

Forward EV/Sales

7.13x

Forward P/E

10.89x

Forward P/S

6.94x

P/B ratio

50.53x

P/S ratio

25.9x

Price / tangible book value

86.04x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-46.08%
EBITDA margin	-41.25%
Gross margin	53.01%
Operating margin	-46.08%
Pretax margin	-183.98%
Profit margin	-183.98%
Profit per employee	$-2.1M
Profitable quarters	1
Revenue per employee	$535,731
ROA	-18.14%
ROA (5Y)	-29.54%
ROCE	-28.02%
ROE	-837.08%
ROE (5Y)	-196.38%
ROIC	-34.97%
SBC / revenue	15.94%

Metric

Value

EBIT margin

-46.08%

EBITDA margin

-41.25%

Gross margin

53.01%

Operating margin

-46.08%

Pretax margin

-183.98%

Profit margin

-183.98%

Profit per employee

$-2.1M

Profitable quarters

Revenue per employee

$535,731

ROA

-18.14%

ROA (5Y)

-29.54%

ROCE

-28.02%

ROE

-837.08%

ROE (5Y)

-196.38%

ROIC

-34.97%

SBC / revenue

15.94%

Metric	Value
EPS growth quarters	3
EPS growth years	0
Net income growth quarters	2
Net income growth years	0
Revenue growth	1,875.05%
Revenue growth (Q)	6,322.66%
Revenue growth (QoQ)	136.44%
Revenue growth 10Y	-7.69%
Revenue growth 3Y	57.11%
Revenue growth 5Y	11.31%
Revenue growth quarters	6
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

1,875.05%

Revenue growth (Q)

6,322.66%

Revenue growth (QoQ)

136.44%

Revenue growth 10Y

-7.69%

Revenue growth 3Y

57.11%

Revenue growth 5Y

11.31%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-1.1M
Depreciation and amortization	$4.1M
EBIT	$-39.5M
EBITDA	$-35.4M
EPS	$-0.98
FCF per share	$-0.32
Financing cash flow	$92.6M
Free cash flow	$-115.2M
Free cash flow minus SBC	$-128.9M
Gross profit	$45.4M
Investing cash flow	$24.1M
Net borrowing	$92.8M
Net cash flow	$2.6M
Net income	$-336.7M
Operating cash flow minus SBC	$-127.8M
Operating income	$-39.5M
Revenue	$85.7M
Stock-based compensation	$13.7M

Metric

Value

Capital expenditures

$-1.1M

Depreciation and amortization

$4.1M

EBIT

$-39.5M

EBITDA

$-35.4M

EPS

$-0.98

FCF per share

$-0.32

Financing cash flow

$92.6M

Free cash flow

$-115.2M

Free cash flow minus SBC

$-128.9M

Gross profit

$45.4M

Investing cash flow

$24.1M

Net borrowing

$92.8M

Net cash flow

$2.6M

Net income

$-336.7M

Operating cash flow minus SBC

$-127.8M

Operating income

$-39.5M

Revenue

$85.7M

Stock-based compensation

$13.7M

Metric	Value
Altman Z-Score	-12.66
Book value per share	$0.12
Debt / equity	2.26
Goodwill	$15.2M
Interest coverage	-4.06
Long-term assets	$35.9M
Long-term liabilities	$97.4M
Net cash (debt)	$-60.1M
Net cash / market cap	-2.71%
Net debt / equity	1.38
Piotroski F-Score	4
Property, plant and equipment	$16.9M
Shareholders' equity	$43.6M
Tangible book value	$25.8M
Tangible book value per share	$0.07
Total assets	$170.3M
Total cash	$38.2M
Total debt	$98.3M
Total liabilities	$126.7M
WACC	9.24%

Metric

Value

Altman Z-Score

-12.66

Book value per share

$0.12

Debt / equity

2.26

Goodwill

$15.2M

Interest coverage

-4.06

Long-term assets

$35.9M

Long-term liabilities

$97.4M

Net cash (debt)

$-60.1M

Net cash / market cap

-2.71%

Net debt / equity

1.38

Piotroski F-Score

Property, plant and equipment

$16.9M

Shareholders' equity

$43.6M

Tangible book value

$25.8M

Tangible book value per share

$0.07

Total assets

$170.3M

Total cash

$38.2M

Total debt

$98.3M

Total liabilities

$126.7M

WACC

9.24%

Metric	Value
Asset turnover	0.63
Current assets	$134.4M
Current liabilities	$29.4M
Current ratio	4.58
Net working capital	$67.9M
Quick ratio	3.76
Working capital	$105M
Working capital turnover	1.19

Metric

Value

Asset turnover

0.63

Current assets

$134.4M

Current liabilities

$29.4M

Current ratio

4.58

Net working capital

$67.9M

Quick ratio

3.76

Working capital

$105M

Working capital turnover

1.19

Metric	Value
Buyback yield / dilution	-18.38%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.16
Shareholder yield	-18.38%

Metric

Value

Buyback yield / dilution

-18.38%

Dividend per share

$0.00

Dividend yield

Last dividend

$0.16

Shareholder yield

-18.38%

Metric	Value
10Y price change	-76.81%
10Y return CAGR	-13.6%
10Y total return	-76.81%
150-day SMA	$5.63
1D price change	-1.06%
1M price change	-21.87%
1M total return	-21.87%
1W price change	-11.35%
1W total return	-11.35%
1Y price change	40.81%
1Y return CAGR	40.85%
1Y total return	40.81%
20-day SMA	$7.10
200-day SMA	$5.24
3M price change	11.72%
3M total return	11.72%
3Y price change	499.51%
3Y return CAGR	81.64%
3Y total return	499.51%
50-day SMA	$7.24
50-day SMA vs 200-day SMA	50over200
52-week high	$8.98
52-week high date	2026-09-30
52-week low	$3.04
52-week low date	2026-03-25
5Y price change	34.56%
5Y return CAGR	6.12%
5Y total return	34.56%
6M price change	52.9%
6M total return	52.9%
All-time high	$69.45
All-time high date	2015-08-06
All-time low	$0.65
All-time low date	2024-12-16
Average true range (ATR)	$0.39
Average volume	4.6M
Beta (1Y)	0.85
Beta (2Y)	1.61
Beta (5Y)	0.92
Change from 52-week high	-32.24%
Change from 52-week low	100.16%
Change from all-time high	-91.28%
Change from all-time low	829.68%
Change from open	0.58%
Day's gap	-1.63%
Dollar volume	$18.8M
High price	$6.35
Low price	$6.04
Monthly RSI	60.43
Open price	$6.05
Position in 52-week range	14.52%
Premarket change	0.98%
Premarket close	$6.15
Premarket price	$6.21
Premarket volume	2.1K
Previous close	$6.15
Price vs 150-day SMA	7.55%
Price vs 20-day SMA	-14.71%
Price vs 200-day SMA	15.47%
Price vs 50-day SMA	-16.33%
Relative volume	0.68
RSI	34.28
Sharpe ratio	0.76
Sharpe ratio (3Y)	1.03
Sharpe ratio (5Y)	0.44
Sortino ratio	1.36
Sortino ratio (3Y)	1.89
Sortino ratio (5Y)	0.79
Volume	3.1M
Weekly RSI	49.97
YTD price change	44.86%
YTD total return	44.86%

Metric

Value

10Y price change

-76.81%

10Y return CAGR

-13.6%

10Y total return

-76.81%

150-day SMA

$5.63

1D price change

-1.06%

1M price change

-21.87%

1M total return

-21.87%

1W price change

-11.35%

1W total return

-11.35%

1Y price change

40.81%

1Y return CAGR

40.85%

1Y total return

40.81%

20-day SMA

$7.10

200-day SMA

$5.24

3M price change

11.72%

3M total return

11.72%

3Y price change

499.51%

3Y return CAGR

81.64%

3Y total return

499.51%

50-day SMA

$7.24

50-day SMA vs 200-day SMA

50over200

52-week high

$8.98

52-week high date

2026-09-30

52-week low

$3.04

52-week low date

2026-03-25

5Y price change

34.56%

5Y return CAGR

6.12%

5Y total return

34.56%

6M price change

52.9%

6M total return

52.9%

All-time high

$69.45

All-time high date

2015-08-06

All-time low

$0.65

All-time low date

2024-12-16

Average true range (ATR)

$0.39

Average volume

4.6M

Beta (1Y)

0.85

Beta (2Y)

1.61

Beta (5Y)

0.92

Change from 52-week high

-32.24%

Change from 52-week low

100.16%

Change from all-time high

-91.28%

Change from all-time low

829.68%

Change from open

0.58%

Day's gap

-1.63%

Dollar volume

$18.8M

High price

$6.35

Low price

$6.04

Monthly RSI

60.43

Open price

$6.05

Position in 52-week range

14.52%

Premarket change

0.98%

Premarket close

$6.15

Premarket price

$6.21

Premarket volume

2.1K

Previous close

$6.15

Price vs 150-day SMA

7.55%

Price vs 20-day SMA

-14.71%

Price vs 200-day SMA

15.47%

Price vs 50-day SMA

-16.33%

Relative volume

0.68

RSI

34.28

Sharpe ratio

0.76

Sharpe ratio (3Y)

1.03

Sharpe ratio (5Y)

0.44

Sortino ratio

1.36

Sortino ratio (3Y)

1.89

Sortino ratio (5Y)

0.79

Volume

3.1M

Weekly RSI

49.97

YTD price change

44.86%

YTD total return

44.86%

Metric	Value
Float	194.6M
Float percentage	54.35%
Shares change (QoQ)	16.76%
Shares change (YoY)	18.38%
Shares held by insiders	11.71%
Shares held by institutions	39.33%
Shares outstanding	358M
Short % of float	24.43%
Short % of shares	13.28%
Short ratio	10.2 days

Metric

Value

Float

194.6M

Float percentage

54.35%

Shares change (QoQ)

16.76%

Shares change (YoY)

18.38%

Shares held by insiders

11.71%

Shares held by institutions

39.33%

Shares outstanding

358M

Short % of float

24.43%

Short % of shares

13.28%

Short ratio

10.2 days

Precigen, Inc. (PGEN)

Price

Financial snapshot

Fair-value bridge

Latest news · PGEN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PGEN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PGEN

Frequently asked questions